参考文献 |
---|
He M, Yu W, Chang C, Miyamoto H, Liu X, Jiang K, et al. Estrogen receptor α promotes lung cancer cell invasion via increase of and cross-talk with infiltrated macrophages through the CCL2/CCR2/MMP9 and CXCL12/CXCR4 signaling pathways. Mol Oncol. 2020;14:1779-1799 pubmed 出版商
|
Son H, Kim N, Song C, Lee S, Lee H, Surh Y. 17β-Estradiol reduces inflammation and modulates antioxidant enzymes in colonic epithelial cells. Korean J Intern Med. 2020;35:310-319 pubmed 出版商
|
Song C, Kim N, Kim D, Lee H, Surh Y. 17-β estradiol exerts anti-inflammatory effects through activation of Nrf2 in mouse embryonic fibroblasts. PLoS ONE. 2019;14:e0221650 pubmed 出版商
|
Herber C, Krause W, Wang L, Bayrer J, Li A, Schmitz M, et al. Estrogen signaling in arcuate Kiss1 neurons suppresses a sex-dependent female circuit promoting dense strong bones. Nat Commun. 2019;10:163 pubmed 出版商
|
Nardone A, Weir H, Delpuech O, Brown H, De Angelis C, Cataldo M, et al. The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance. Br J Cancer. 2019;120:331-339 pubmed 出版商
|
Singh K, Munuganti R, Lallous N, Dalal K, Yoon J, Sharma A, et al. Benzothiophenone Derivatives Targeting Mutant Forms of Estrogen Receptor-? in Hormone-Resistant Breast Cancers. Int J Mol Sci. 2018;19: pubmed 出版商
|
Heidari P, Deng F, Esfahani S, Leece A, Shoup T, Vasdev N, et al. Pharmacodynamic imaging guides dosing of a selective estrogen receptor degrader. Clin Cancer Res. 2015;21:1340-7 pubmed 出版商
|
Fu X, Creighton C, Biswal N, Kumar V, Shea M, Herrera S, et al. Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase. Breast Cancer Res. 2014;16:430 pubmed 出版商
|
Morrison G, Fu X, Shea M, Nanda S, Giuliano M, Wang T, et al. Therapeutic potential of the dual EGFR/HER2 inhibitor AZD8931 in circumventing endocrine resistance. Breast Cancer Res Treat. 2014;144:263-72 pubmed 出版商
|
Luo N, Guan Q, Zheng L, Qu X, Dai H, Cheng Z. Estrogen-mediated activation of fibroblasts and its effects on the fibroid cell proliferation. Transl Res. 2014;163:232-41 pubmed 出版商
|
Lit L, Scott S, Zhang H, Stebbing J, Photiou A, Giamas G. LATS2 is a modulator of estrogen receptor alpha. Anticancer Res. 2013;33:53-63 pubmed
|
Keller P, Arendt L, Skibinski A, Logvinenko T, Klebba I, Dong S, et al. Defining the cellular precursors to human breast cancer. Proc Natl Acad Sci U S A. 2012;109:2772-7 pubmed 出版商
|
Ibarra J, Rogers L, Kyshtoobayeva A, Bloom K. Fixation time does not affect the expression of estrogen receptor. Am J Clin Pathol. 2010;133:747-55 pubmed 出版商
|
Singh P, Ragavan N, Ashton K, Basu P, Nadeem S, Nicholson C, et al. Quantified gene expression levels for phase I/II metabolizing enzyme and estrogen receptor levels in benign prostate from cohorts designated as high-risk (UK) versus low-risk (India) for adenocarcinoma at this organ site: a preliminary study. Asian J Androl. 2010;12:203-14 pubmed 出版商
|
Gomez Fernandez C, Mejias A, Walker G, Nadji M. Immunohistochemical expression of estrogen receptor in adenocarcinomas of the lung: the antibody factor. Appl Immunohistochem Mol Morphol. 2010;18:137-41 pubmed 出版商
|
Rocha R, Nunes C, Sanches F, Rocha G, Oliveira F, Reis Filho J, et al. Rabbit antibodies for hormone receptors and HER2 evaluation in breast cancer. Rev Assoc Med Bras (1992). 2009;55:163-8 pubmed
|
Kelly J, Singh M, Stringfellow H, Walsh M, Nicholson J, Bahrami F, et al. Derivation of a subtype-specific biochemical signature of endometrial carcinoma using synchrotron-based Fourier-transform infrared microspectroscopy. Cancer Lett. 2009;274:208-17 pubmed 出版商
|
Singh M, Stringfellow H, Taylor S, Ashton K, Ahmad M, Abdo K, et al. Elevated expression of CYP1A1 and gamma-SYNUCLEIN in human ectopic (ovarian) endometriosis compared with eutopic endometrium. Mol Hum Reprod. 2008;14:655-63 pubmed 出版商
|